Asaren is a genetic platform that utilizes artificial intelligence and real-world evidence to enhance personalized medicine by predicting treatment outcomes and discovering life-saving technologies. The platform aggregates over 2 million data points and 679,000 unique datasets to improve patient care and support healthcare providers in making informed decisions.
Funding
$8.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Personalized medicine is hindered by the difficulty of accurately predicting treatment outcomes and identifying effective therapies for individual patients. The lack of comprehensive data and analytical tools limits the ability to tailor treatments based on a patient's unique genetic and clinical profile.
Solution
Asaren provides an AI-powered platform that leverages real-world evidence and genetic data to improve personalized medicine. The platform aggregates a large volume of real-world evidence data points and unique datasets to predict treatment performance and advance personalized treatments. By applying artificial intelligence to this data, Asaren aims to support healthcare providers in making more informed decisions and discovering life-saving technologies. The platform facilitates data collaboration to enhance patient care and potentially create new revenue streams for healthcare providers.
Target Audience
The primary users are healthcare providers and life science organizations seeking to enhance patient care, improve treatment outcomes, and drive innovation through data-driven personalized solutions.
Features
- Aggregates over 2 million real-world evidence data points.
- Integrates 679,000+ unique datasets.
- AI-powered analytics to predict treatment outcomes.
- Data collaboration tools for healthcare providers.
- Supports personalized treatment strategies.